TOTAL VOLUME:

$154.7b

24H VOL:

$279,496,801

24H TRANSACTIONS:

2,984,640,614

OPEN INTEREST:

$1,923,931,766

416,910

Markets across

40,107

events

MATCHED EVENTS:

4,571

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Tour
All
Sports
Florida vs Columbus: 1st Period Spread
kalshi

Florida vs Columbus: 1st Period Spread

Volume:
$1,702

Florida wins by over 1.5 goals

 - Kalshi

Florida wins by over 1.5 goals - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Oct 13, 2026

Closed: Oct 13, 7:06 PM EST

kalshi

Kalshi

View
Join Kalshi and score $25 for your first trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Florida wins by over 1.5 goals

View
0%
Yes 0¢No 100¢
—
N/A
$1,607
N/A
N/A
$1,532
Settled
No
kalshi

Columbus wins by over 1.5 goals

0%
Yes 0¢No 100¢
—
N/A
$95
N/A
N/A
$95
Settled
No
Total markets: 2

Description

This market focuses on predicting whether either team will dominate the opposition by a significant margin in the opening period of an NHL game. It reflects the potential for early-game momentum and strategic advantages between the two teams. The outcome depends solely on the score differential within the first period, ignoring later developments in the match.

Kalshi

The event determines whether either Florida or Columbus will win the first period by more than a 1.5 goal margin in their NHL game scheduled for October 13, 2026. If Columbus achieves this dominance, the market resolves to Yes under the first rule. Conversely, if Florida secures a comparable lead, the second rule triggers a Yes outcome. Both rules share identical secondary conditions: overtime in the third period is excluded from consideration, and if the game is postponed but starts within 48 hours of its original time, the market remains active and resolves based on the official result. If the game is cancelled or fails to start within this 48-hour window, all markets resolve to a fair price, ensuring equitable treatment for all participants based on these unified secondary guidelines.